INmune Bio Inc (INMB) support and resistance · rev $50.0K
INmune Bio Inc (INMB) is a biotechnology company listed on US.
This page maps INmune Bio Inc (INMB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
INMB currently screens at market cap $33.5M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new INMB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the INMB quote page for the session range and the stock page for the full model.
Not investment advice.